Cargando…
The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer
Background: Although growing evidence have demonstrated that long non-coding RNA ZEB1-AS1 was aberrantly expressed in various types of cancers and can be used as a prognostic marker in cancer, the results remain inconclusive. Therefore, we performed this meta-analysis to evaluate the prognostic valu...
Autores principales: | Wu, Ying, Ding, Ming, Wei, Shuzhen, Wu, Ting, Xu, Rongrong, Zhu, Xiaoli, Liu, Hongbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6216015/ https://www.ncbi.nlm.nih.gov/pubmed/30405838 http://dx.doi.org/10.7150/jca.27263 |
Ejemplares similares
-
Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer
por: Su, Wenjing, et al.
Publicado: (2017) -
Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis
por: Cheng, Sixiang, et al.
Publicado: (2020) -
A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma
por: Lv, Qiao-Li, et al.
Publicado: (2016) -
Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma
por: Siena, Ádamo Davi Diógenes, et al.
Publicado: (2019) -
Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis
por: Zhou, Xi, et al.
Publicado: (2019)